1. Guillain-Barré syndrome with exaggerated pleocytosis and anti-GM1 ganglioside antibodies.
- Author
-
Doctor GT, Alexander SK, and Radunovic A
- Subjects
- Aged, 80 and over, Autoantibodies blood, Autoantibodies cerebrospinal fluid, Guillain-Barre Syndrome cerebrospinal fluid, Guillain-Barre Syndrome drug therapy, Humans, Immunoglobulins, Intravenous therapeutic use, Leukocytosis cerebrospinal fluid, Leukocytosis drug therapy, Male, Autoantibodies immunology, G(M1) Ganglioside immunology, Guillain-Barre Syndrome immunology, Leukocytosis immunology
- Abstract
An 81-year-old man presented with fever, confusion and rapidly-progressive flaccid tetraparesis. Clinical presentation and neurophysiology were consistent with a severe axonal polyneuropathy. Anti-GM1 and Campylobacter serology were both positive, consistent with postinfectious axonal-variant Guillain-Barré syndrome (GBS). GBS is characterised by albuminocytological dissociation, where an elevated protein and acellular cerebrospinal fluid are typical. However, in this case, CSF analysis revealed an exaggerated pleocytosis (72 white blood cells (WBC)/mm
3 ). No source of central nervous system infection or inflammation was identified despite thorough investigation. The patient was treated with intravenous immunoglobulin and intensive rehabilitation.Albuminocytological dissociation classically distinguishes GBS from infective causes of flaccid weakness (eg, enteroviruses, flaviviruses and HIV). Diagnostic criteria frequently cite a pleocytosis of <50 WBC/mm3 as required in the diagnosis of GBS. However, this case demonstrates that pleocytosis exceeding this level can occur in the presence of convincing evidence of GBS and without demonstrable neurotropic infection., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)- Published
- 2018
- Full Text
- View/download PDF